STC-008

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameSTC-008
Drug Alias NameSTC008STC-008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGhrelin/growth hormone secretagogue receptor agonists
TargetsGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsSolid tumoursLarge intestine neoplasmCachexia +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Nuohe Shengtai Biology Tech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Xinghao Holdings Partnership Enterprise (Limited Partnership)Chengdu Nuohe Shengtai Biology Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLarge intestine neoplasmCachexia +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A